tiprankstipranks
Trending News
More News >
Cyfuse Biomedical K.K. (JP:4892)
:4892
Japanese Market

Cyfuse Biomedical K.K. (4892) Income Statement

Compare
0 Followers

Cyfuse Biomedical K.K. Income Statement

Last quarter (Q2 2025), Cyfuse Biomedical K.K.'s total revenue was ¥5.21M, a decrease of -28.64% from the same quarter last year. In Q2, Cyfuse Biomedical K.K.'s net income was ¥-239.53M. See Cyfuse Biomedical K.K.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 231.00M¥ 54.45M¥ 61.11M¥ 374.48M¥ 708.25M
Gross Profit
¥ 78.40M¥ 1.56M¥ -378.00K¥ 223.93M¥ 568.20M
Operating Expenses
¥ 906.58M¥ 897.69M¥ 697.06M¥ 649.02M¥ 497.63M
Depreciation and Amortization
¥ 35.49M¥ 36.02M¥ 38.12M¥ 54.28M¥ 18.50M
EBITDA
¥ -792.68M¥ -860.12M¥ -659.31M¥ -370.81M¥ 89.07M
Operating Income
¥ -828.18M¥ -896.13M¥ -697.44M¥ -425.09M¥ 70.57M
Other Income/Expenses
¥ 66.88M¥ 26.39M¥ 111.25M¥ -46.86M¥ 74.34M
Pretax Income
¥ -761.30M¥ -869.75M¥ -586.19M¥ -471.95M¥ 144.91M
Net Income
¥ -763.84M¥ -872.24M¥ -589.21M¥ -473.96M¥ 142.91M
Per Share Metrics
Basic EPS
¥ -86.78¥ -108.34¥ -75.42¥ -60.97¥ 19.94
Diluted EPS
¥ -86.78¥ -108.34¥ -75.42¥ -60.97¥ 19.94
Weighted Average Shares Outstanding
8.80M 8.05M 7.81M 7.77M 7.17M
Weighted Average Shares Outstanding (Diluted)
8.80M 8.05M 7.81M 7.77M 7.17M
Currency in JPY

Cyfuse Biomedical K.K. Earnings and Revenue History